CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,751,623 | -66.1% | 317,323 | -47.5% | 0.00% | -50.0% |
Q2 2023 | $5,159,535 | +119.1% | 604,161 | +135.8% | 0.00% | +100.0% |
Q1 2023 | $2,354,938 | -9.8% | 256,250 | +0.1% | 0.00% | 0.0% |
Q4 2022 | $2,611,000 | -37.5% | 255,877 | -9.9% | 0.00% | -50.0% |
Q3 2022 | $4,180,000 | +41.1% | 283,951 | +2.8% | 0.00% | +100.0% |
Q2 2022 | $2,962,000 | +57.9% | 276,202 | +215.2% | 0.00% | 0.0% |
Q3 2021 | $1,876,000 | – | 87,634 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
Miura Global Management | 780,000 | $7,963,800 | 4.01% |
RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |